Delivery Order SPE2DB20D2104-SPE2DB24FR16N
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of a pharmaceutical product, RINVOQ ER 15 MG TABLET, to the Defense Logistics Agency (DLA). The contract, valued at $24,147.11, is a firm-fixed-price delivery order with an ultimate completion date of April 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies, including the prescription drug RINVOQ ER 45 MG TABLET. The award, valued at $9,030.57, was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,697.38 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 15 MG TABLET. The order has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $24,219.52 for the supply of RINVOQ ER 15 MG TABLET. The contract was awarded on December 12, 2022 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 13, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,714.94 for the supply of RINVOQ ER 15 MG TABLET products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare provider for the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products. The award, valued at $17,908.87, is a firm fixed-price delivery order with a completion date of February 13, 2024. The contract covers the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,976.63 for the pharmaceutical product RINVOQ ER 15 MG TABLET. The award, which has a completion date of May 11, 2022, is a firm fixed-price contract and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,383.92 for the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense's healthcare needs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $15,800.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S, with a completion date of December 8, 2023. The contract is a firm fixed-price agreement, awarded through full and open competition without any set-aside designations. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $12,143.49 for the supply of RINVOQ ER 30 MG TABLET UU 30S medical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, on December 21, 2023, with an ultimate completion date of December 22, 2023. The contract is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR16NDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract, valued at $10,001.24, was awarded by the Defense Logistics Agency (DLA) and has a completion date of November 15, 2023. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 11/14/23 |